MaxCyte, Inc. Form 8-K Summary
Business Context and Reporting Period
MaxCyte, Inc. (MXCT), a Delaware corporation, filed this Current Report on Form 8-K on June 17, 2026. The filing reports the results of the Company's 2026 Annual Meeting of Stockholders held on the same date. The Company is classified as an emerging growth company.
Financial Metrics
This filing does not contain financial performance data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing details the outcome of two shareholder proposals:
- Proposal 1 (Election of Class II Directors): Stockholders elected three nominees. Patrick Balthrop received 39,760,379 votes for; Cynthia Collins received 46,886,614 votes for; and Stanley Erck received 40,908,701 votes for. Each nominee received 17,814,976 broker non-votes.
- Proposal 2 (Ratification of Auditor): Stockholders ratified the selection of CohnReznick LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The vote count was 70,227,193 for, 46,732 against, and 30,256 abstentions.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly reports the voting results of the Annual Meeting.
Key Facts for Investor Verification
- Verify the definitive proxy statement filed on April 29, 2026, for detailed background on the director nominees and auditor selection.
- Confirm the total number of shares outstanding to calculate the percentage of votes cast for each proposal.
- Note the significant number of broker non-votes (17,814,976) recorded for the director elections, which may impact future voting dynamics.
- Confirm that CohnReznick LLP is the appointed auditor for the fiscal year ending December 31, 2026.